DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Nettles JH, Stanton RA, Broyde J. , et al.
Asymmetric binding to NS5A by daclatasvir (BMS-790052) and analogs suggests two novel modes of HCV inhibition.
J Med Chem 2014;
57 (23) 10031-10043
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.